Data / Drug companies / Esomeprazole
Esomeprazole: 26 companies and 36 products in the FDA NDC directory
Esomeprazole is listed in the FDA National Drug Code Directory by 26 companies, with 36 products in commercial distribution. 36 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, delayed release, and the newest product started marketing on August 27, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 26
- Products
- 36
- Generic (ANDA) products
- 36 (100.0%)
- Application numbers
- 4
- Routes
- Oral
- Brand names
- Riopan, Berkley and Jensen Heartburn Treatment, Foster and Thrive Acid Reducer
- openFDA record search
- api.fda.gov
Companies that list esomeprazole
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amazon.com Services LLC | 5 | capsule, delayed release | Generic drugs (ANDA) | August 27, 2026 |
| Dolgencorp, Inc. (dollar General & Rexall) | 3 | capsule, delayed release | Generic drugs (ANDA) | May 3, 2024 |
| L. Perrigo Company | 3 | capsule, delayed release | Generic drugs (ANDA) | April 24, 2024 |
| Kroger Company | 2 | capsule, delayed release | Generic drugs (ANDA) | May 13, 2022 |
| Macleods Pharmaceuticals Limited | 2 | capsule, delayed release | Generic drugs (ANDA) | October 23, 2024 |
| American Sales Company | 1 | capsule, delayed release | Generic drugs (ANDA) | September 26, 2017 |
| Amerisource Bergen | 1 | capsule, delayed release | Generic drugs (ANDA) | March 13, 2020 |
| Army and Air Force Exchange Service | 1 | capsule, delayed release | Generic drugs (ANDA) | December 4, 2017 |
| Bjwc | 1 | capsule, delayed release | Generic drugs (ANDA) | September 25, 2017 |
| CVS Pharmacy | 1 | capsule, delayed release | Generic drugs (ANDA) | September 25, 2017 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | capsule, delayed release | Generic drugs (ANDA) | March 13, 2024 |
| Cardinal Health 110, LLC. DBA Leader | 1 | capsule, delayed release | Generic drugs (ANDA) | April 2, 2025 |
| Costco Wholesale Company | 1 | capsule, delayed release | Generic drugs (ANDA) | September 22, 2017 |
| H E B | 1 | capsule, delayed release | Generic drugs (ANDA) | August 6, 2020 |
| HyVee Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | January 28, 2026 |
| Meijer Distribution Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | September 22, 2017 |
| Meijer, Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | March 21, 2024 |
| Opmx LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | March 4, 2026 |
| Publix Super Markets Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | September 29, 2017 |
| Safeway | 1 | capsule, delayed release | Generic drugs (ANDA) | December 7, 2022 |
| Sam's West Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | December 6, 2019 |
| Strategic Sourcing Services LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | February 15, 2024 |
| Target Corporation | 1 | capsule, delayed release | Generic drugs (ANDA) | September 22, 2017 |
| Wal-Mart Stores Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | October 5, 2017 |
| Walgreen Company | 1 | capsule, delayed release | Generic drugs (ANDA) | March 14, 2024 |
| Walmart Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | March 16, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, delayed release | 36 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 36 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Proton Pump Inhibitor | 36 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.